Contraindications to Naltrexone
The absolute contraindication to naltrexone is current opioid use, including prescribed opioid analgesics, as it will precipitate severe opioid withdrawal. 1
Absolute Contraindications
Based on the most recent 2026 British Association for Psychopharmacology guidelines and FDA labeling, naltrexone is contraindicated in:
- Current opioid use (including prescribed opioid analgesia) 2, 1
- Current opioid dependence, including patients maintained on:
- Acute opioid withdrawal 1
- Positive urine screen for opioids 1
- Failed naloxone challenge test 1
- Known hypersensitivity to naltrexone or any product components 1
Critical Timing Considerations
Patients must be opioid-free for at least 7 days before starting naltrexone to avoid precipitating severe withdrawal. 2, 1 This is a safety-critical requirement that directly impacts morbidity.
Special Opioid Situations
For patients who received long-acting buprenorphine within the past 12 months, naltrexone is best avoided entirely, as it may precipitate withdrawal even after extended opioid-free periods. 2
Relative Contraindications and Cautions
Hepatic Impairment
The evidence on hepatic contraindications has evolved significantly:
- Child-Pugh B and C cirrhosis or acute alcoholic hepatitis: Use with caution due to risk of accumulation of naltrexone's active metabolites 2
- Historical hepatotoxicity concerns have been challenged - naltrexone may be used in patients with alcohol-associated liver disease 2
- Dose-related hepatotoxicity occurs only at doses much higher (up to 300 mg/day) than the standard 50 mg/day dose 1
Procedural Planning
Naltrexone must be discontinued before any procedure requiring opioid analgesia (e.g., endoscopies using fentanyl), as it will block the analgesic effect. 3 This is a practical consideration that affects quality of life and procedural safety.
Common Clinical Pitfalls
- Failing to verify opioid-free status: Always confirm patients are truly opioid-free for ≥7 days before initiation
- Overlooking prescribed opioids: Many patients don't consider their prescribed pain medications as "opioids"
- Inadequate washout from long-acting buprenorphine: Standard 7-day washout is insufficient for long-acting formulations
- Not planning for surgical/procedural needs: Patients may require opioid analgesia unexpectedly